about
Liquid chromatography-tandem and MALDI imaging mass spectrometry analyses of RCL2/CS100-fixed, paraffin-embedded tissues: proteomics evaluation of an alternate fixative for biomarker discoveryRCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells.Characterization of resident B cells of vascular walls in human atherosclerotic patients.Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cellsHER2 overexpression a major risk factor for recurrence in pT1a-bN0M0 breast cancer: results from a French regional cohort.Macular lymphocytic arteritis: three cases questioning its classification as primary lymphocytic vasculitis.Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.Is the mannose-6-phosphate/insulin-like growth factor 2 receptor coded by a breast cancer suppressor gene?Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies.Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis.Acinar cell carcinoma of the pancreas in a young patient with cells immunoreactive for somatostatin.Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH).[Update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].[An early onset and aggressive form of amyloid angiopathy].[Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France].[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].Stereotactic vacuum biopsy of calcifications with a handheld portable biopsy system: a validation studyImmunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies[Vaginal metastases of breast cancer]Comparative study of the accuracy of breast resection in oncoplastic surgery and quadrantectomy in breast cancerPre-operative arterial embolisation of a uterine rhabdomyosarcoma in a 14-year-old girl[Carcinoma with false negative mammogram: when and how?][Lumpectomy vs oncoplastic surgery for breast-conserving therapy of cancer. A prospective study about 99 patients][Breast macrobiopsy: the need for standardized terminology][A rare nail lesion][A rare scrotal lesion with disputed aetiology]Solitary subungual keratoacanthoma arising in an MSH2 germline mutation carrier: confirmation of a relationship by immunohistochemical analysis[An unusual tumor of the endometrium][GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting][Carcinoma with false negative mammogram: when and how?]
P50
Q30478449-55513088-B131-4EEB-BC5E-0D2061F363BCQ33241448-3AFC708F-75AF-4DC4-9ABE-9B871D90A43FQ34955086-82058189-7540-4D85-A120-CCAF60CF5141Q36413984-378FF2E6-C977-41AD-A6A9-23FE98682FCCQ37595263-20BEE393-CB63-42A4-84B3-42DBDB075A9AQ38170985-A5CD689A-B836-46C2-872E-61C2163CE3F2Q40750156-DB1D439A-E7B0-453E-8A14-13293269CEE0Q46581524-63FAFEBA-0534-424C-9FE2-8049BCD2AE74Q51101783-4C9D9C3F-F2A8-410F-915F-747A01764167Q53308983-6C40F242-FAF2-4CEA-835A-8F04C88213B7Q53555112-E9B60691-01C5-4A66-8FA7-BB6CEEA9D78FQ54538229-61F18B90-5EFF-45E5-A970-9668C349C2CAQ54634889-22237036-DE4C-4072-ACD2-F099E7860BA0Q54762749-F3D73910-E440-4620-84AE-F9B1399CB113Q55069875-DDC78CC4-48C3-40A7-B0D8-79C10C463446Q55069887-48F7C537-0E0E-4AD2-A2AA-30588EF7B7C4Q56784221-7F1047CB-C9B4-41C2-A55B-5598A5038C8CQ61800299-6C72F827-230D-4382-8FD2-AE673DC6668FQ77914362-53547CA6-8F7B-492D-BCAB-E1E7C2E6891BQ79412216-5EC627F6-CBC5-4881-B2F6-F41CA17806C9Q80485087-B4CB66BB-EF89-4CDD-8FF2-BF8091FEC0CAQ81363659-56E35B5B-2A14-43B4-9A07-1DECC1D42DF9Q82791076-E15282D8-2CDD-412A-9A4A-0CDF8E82E1E6Q82893403-1A64289D-8C33-44A1-A40C-4A2A1D594E2DQ83423729-7F535CCF-7C2B-4098-97C7-7F31A7D91F67Q84160555-63EA9B60-13D8-4C38-B87D-346EBEA6DBECQ84230339-32ECDD22-01D9-4671-BAD0-394CB079CBE8Q84260883-74B68F10-D4E9-41F7-B8C1-5CE3D88332D2Q93137752-8C8585AE-BDDE-42BF-AF21-A1A31BBA2558Q94427944-1D84140B-526E-4EFF-8F20-8ECE94397E4C
P50
description
researcher
@en
wetenschapper
@nl
name
Pascal Roger
@en
Pascal Roger
@nl
type
label
Pascal Roger
@en
Pascal Roger
@nl
prefLabel
Pascal Roger
@en
Pascal Roger
@nl
P106
P31
P496
0000-0002-4040-5892